Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate + Oxaliplatin in Advanced Esophago-gastric Cancer
NCT01178944Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Sep 2010
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pralatrexate in esophageal carcinoma, Gastric carcinoma (GC), gastroesophageal junction carcinoma (GEJ), sponsored by Roswell Park Comprehensive Cancer Center. Started Sep 2010; status: completed.
02
Drugs
pralatrexate
03
Conditions
esophageal carcinomaGastric carcinoma (GC)gastroesophageal junction carcinoma (GEJ)
Beyond the preview
Go deeper on NCT01178944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178944.